BREAST CANCER

>

Latest News

Tan Reviews Updates on T-DXd in HER2-Low and -Ultralow Metastatic Breast Cancer
Tan Reviews Updates on T-DXd in HER2-Low and -Ultralow Metastatic Breast Cancer

May 16th 2025

During a Community Case Forum event, Antoinette R. Tan, MD, MHS, discussed the DESTINY-Breast04 and DESTINY-Breast06 trials in HER2-low and -ultralow breast cancer.

Samuraciclib Shows PFS Benefit in Biomarker-Selected HR+ Breast Cancer
Samuraciclib Shows PFS Benefit in Biomarker-Selected HR+ Breast Cancer

May 15th 2025

Frontline Dato-DXd Looks Promising in NSCLC
Frontline Dato-DXd Looks Promising in NSCLC

May 13th 2025

At 10 Years, Pertuzumab Boosts Survival in Early HER2+ Breast Cancer
At 10 Years, Pertuzumab Boosts Survival in Early HER2+ Breast Cancer

May 13th 2025

Vidal Discusses Differences in Duration and AEs With Adjuvant CDK4/6i in Breast Cancer
Vidal Discusses Differences in Duration and AEs With Adjuvant CDK4/6i in Breast Cancer

May 13th 2025

Video Series
Video Interviews
Podcasts
Latest CME Events & Activities

Community Oncology Connections™: Community Oncologists’ Role in Selecting Optimal Oral SERD Treatment for HR+/HER2– Breast Cancer | Nevada

View More

Community Oncology Connections™: Community Oncologists’ Role in Selecting Optimal Oral SERD Treatment for HR+/HER2– Breast Cancer | Missouri

View More

Community Oncology Connections™: Community Oncologists’ Role in Selecting Optimal Oral SERD Treatment for HR+/HER2– Breast Cancer | New Mexico

View More

Coffee Talk™: Navigating the Impact of HER2/3, TROP2, and PARP from Early Stage to Advanced Breast Cancer Care

View More

Community Practice Connection™: Leveraging Multidisciplinary Teams in an Evolving Treatment Landscape for Early- Stage HR+, HER2- Breast Cancer

View More

How We Do It™: Defining HER2 Low on Your Pathology Reports to Make Informed Decisions in Breast Cancer Treatment

View More

Community Oncology Connections™: Community Oncologists’ Role in Selecting Optimal Oral SERD Treatment for HR+/HER2– Breast Cancer | Indiana

View More

Clinical Case Vignette Series™: 41st Annual Miami Breast Cancer Conference®

View More

Fighting Disparities and Saving Lives: An Exploration of Challenges and Solutions in Cancer Care

View More

24th Annual International Congress on the Future of Breast Cancer® West

July 18-19, 2025

Register Now!

24th Annual International Congress on the Future of Breast Cancer® East

July 11-12, 2025

Register Now!

Differentiating Adverse Events for Antibody-Drug Conjugates Across Solid Tumor Management

View More

Community Practice Connections™: 23rd Annual International Congress on the Future of Breast Cancer West

View More

23rd Annual School of Breast Oncology

November 6-8, 2025

Register Now!

Community Practice Connections™: Navigating Early-Stage HR+/HER2‒- Breast Cancer – Clinical Developments and Innovative Treatments

View More

Community Practice Connections™: Community Oncologists’ Role in Selecting Optimal Oral SERD Treatment for HR+/HER2- Breast Cancer

View More

Community Practice Connections™: Case Discussions in TNBC… Navigating the Latest Advances and Impact of Disparities in Care

View More

Medical Crossfire®: Improving Survival in HR-Positive HER2-Negative Metastatic Breast Cancer – Advances in Selective Estrogen Receptor Targeting Therapies

View More

Annual Hawaii Cancer Conference

January 24-25, 2026

Register Now!

42nd Annual CFS: Chemotherapy Foundation Symposium®: Innovative Cancer Therapy for Tomorrow

View More

The Inaugural Hawaii Breast Cancer: A Multidisciplinary Case-Based Conference

View More

43rd Annual Miami Breast Cancer Conference®

March 5-8, 2026

Register Now!

Medical Crossfire®: Translating Evidence to Clinical Practice in Early-Stage HR+, HER2– Breast Cancer

View More

Updates and Innovations in Nonopioid Pain Management Strategies for Breast Cancer Patients Postsurgical Intervention

View More

School of Breast Oncology® (SOBO) Slide & Lecture Library

Joyce O’Shaughnessy, MD

View More

More News